• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intensive Care Med . Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China:

tetano

Editor, Senior Moderator
Intensive Care Med


. 2020 Aug 20.
doi: 10.1007/s00134-020-06211-2. Online ahead of print.
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study


Jianfeng Xie[SUP] 1 [/SUP], Wenjuan Wu[SUP] 2 [/SUP], Shusheng Li[SUP] 3 [/SUP], Yu Hu[SUP] 4 [/SUP], Ming Hu[SUP] 5 [/SUP], Jinxiu Li[SUP] 6 [/SUP], Yi Yang[SUP] 1 [/SUP], Tingrong Huang[SUP] 7 [/SUP], Kun Zheng[SUP] 8 [/SUP], Yishan Wang[SUP] 9 [/SUP], Hanyujie Kang[SUP] 9 [/SUP], Yingzi Huang[SUP] 1 [/SUP], Li Jiang[SUP] 10 [/SUP], Wei Zhang[SUP] 11 [/SUP], Ming Zhong[SUP] 12 [/SUP], Ling Sang[SUP] 13 [/SUP], Xia Zheng[SUP] 14 [/SUP], Chun Pan[SUP] 1 [/SUP], Ruiqiang Zheng[SUP] 15 [/SUP], Xuyan Li[SUP] 9 [/SUP], Zhaohui Tong[SUP] 16 [/SUP], Haibo Qiu[SUP] 17 [/SUP], Bin Du[SUP] 18 [/SUP]



Affiliations

Abstract

Purpose: An ongoing outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan since December 2019 and spread globally. However, information about critically ill patients with COVID-19 is still limited. We aimed to describe the clinical characteristics and outcomes of critically ill patients with COVID-19 and figure out the risk factors of mortality.
Methods: We extracted data retrospectively regarding 733 critically ill adult patients with laboratory-confirmed COVID-19 from 19 hospitals in China through January 1 to February 29, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were collected. The primary outcome was 28-day mortality. Data were compared between survivors and non-survivors.
Results: Of the 733 patients included in the study, the median (IQR) age was 65 (56-73) years and 256 (34.9%) were female. Among these patients, the median (IQR) APACHE II score was 10 (7 to 14) and 28-day mortality was 53.8%. Respiratory failure was the most common organ failure (597 [81.5%]), followed by shock (20%), thrombocytopenia (18.8%), central nervous system (8.6%) and renal dysfunction (8%). Multivariate Cox regression analysis showed that older age, malignancies, high APACHE II score, high D-dimer level, low PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] level, high creatinine level, high hscTnI level and low albumin level were independent risk factors of 28-day mortality in critically ill patients with COVID-19.
Conclusion: In this case series of critically ill patients with COVID-19 who were admitted into the ICU, more than half patients died at day 28. The higher percentage of organ failure in these patients indicated a significant demand for critical care resources.

Keywords: COVID-19; Critically ill; Mortality; Organ failure.
 
Back
Top Bottom